Of note, the reduction was more evident in hypoxia condition (p = 0.005, one-way ANOVA), indicating that the impact of reduced expression of the IGF2BP3/CD164/CXCR4 oncogenic pathway may be stronger in the tumor microenvironment compared to physiological conditions. The gene discussed is IGF2BP3; the disease is neoplasm.